Klein Peter S
Insider CIK 1478007 · FFIV Director · APTI Director · ACCD Director · DNLI Director · STRC Director · MSFT Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DNLI Denali Therapeutics Inc. | A Award deriv | 2026-06-03 | 2026-06-05 | 19,226 | — | $0 | 19,226 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2026-06-03 | 2026-06-05 | 6,408 | — | $0 | 33,941 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2025-06-03 | 2025-06-05 | 18,111 | — | $0 | 18,111 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2025-06-03 | 2025-06-05 | 6,037 | — | $0 | 27,533 | SEC↗ |
| ACCD Accolade, Inc. | D To issuer deriv | 2025-04-08 | 2025-04-08 | 35,021 | — | $0 | 0 | SEC↗ |
| ACCD Accolade, Inc. | D To issuer deriv | 2025-04-08 | 2025-04-08 | 20,000 | — | $0 | 0 | SEC↗ |
| ACCD Accolade, Inc. | D To issuer deriv | 2025-04-08 | 2025-04-08 | 8,600 | — | $0 | 0 | SEC↗ |
| ACCD Accolade, Inc. | D To issuer | 2025-04-08 | 2025-04-08 | 28,329 | $7.03 | $199.2K | 0 | SEC↗ |
| FFIV F5, INC. | A Award deriv | 2025-03-13 | 2025-03-14 | 934 | — | $0 | 934 | SEC↗ |
| FFIV F5, INC. | M Exercise deriv | 2025-03-12 | 2025-03-14 | 1,309 | — | $0 | 0 | SEC↗ |
| FFIV F5, INC. | M Exercise | 2025-03-12 | 2025-03-14 | 1,309 | — | $0 | 13,333 | SEC↗ |
| FFIV F5, INC. | G Gift | 2024-09-05 | 2024-09-06 | 1,000 | — | $0 | 12,024 | SEC↗ |
| ACCD Accolade, Inc. | A Award deriv | 2024-08-06 | 2024-08-08 | 35,021 | — | $0 | 35,021 | SEC↗ |
| ACCD Accolade, Inc. | M Exercise deriv | 2024-08-06 | 2024-08-08 | 9,196 | — | $0 | 0 | SEC↗ |
| ACCD Accolade, Inc. | M Exercise | 2024-08-06 | 2024-08-08 | 9,196 | — | $0 | 28,329 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2024-05-31 | 2024-06-04 | 17,901 | — | $0 | 17,901 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2024-05-31 | 2024-06-04 | 5,967 | — | $0 | 21,496 | SEC↗ |
| FFIV F5, INC. | A Award deriv | 2024-03-14 | 2024-03-15 | 1,309 | — | $0 | 1,309 | SEC↗ |
| FFIV F5, INC. | M Exercise deriv | 2024-03-13 | 2024-03-15 | 1,770 | — | $0 | 0 | SEC↗ |
| FFIV F5, INC. | M Exercise | 2024-03-13 | 2024-03-15 | 1,770 | — | $0 | 13,024 | SEC↗ |
| FFIV F5, INC. | G Gift | 2023-09-05 | 2023-09-07 | 1,200 | — | $0 | 11,254 | SEC↗ |
| ACCD Accolade, Inc. | A Award deriv | 2023-08-18 | 2023-08-22 | 9,196 | — | $0 | 9,196 | SEC↗ |
| ACCD Accolade, Inc. | M Exercise deriv | 2023-07-25 | 2023-07-27 | 14,060 | — | $0 | 0 | SEC↗ |
| ACCD Accolade, Inc. | M Exercise | 2023-07-25 | 2023-07-27 | 14,060 | — | $0 | 19,133 | SEC↗ |
| STRC Sarcos Technology & Roboti | A Award | 2023-06-14 | 2023-06-16 | 195,059 | — | $0 | 265,066 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 12,649 | — | $0 | 12,649 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2023-06-01 | 2023-06-05 | 4,216 | — | $0 | 15,529 | SEC↗ |
| FFIV F5, INC. | A Award deriv | 2023-03-09 | 2023-03-10 | 1,770 | — | $0 | 1,770 | SEC↗ |
| FFIV F5, INC. | M Exercise deriv | 2023-03-08 | 2023-03-10 | 1,272 | — | $0 | 0 | SEC↗ |
| FFIV F5, INC. | M Exercise | 2023-03-08 | 2023-03-10 | 1,272 | — | $0 | 12,454 | SEC↗ |
| ACCD Accolade, Inc. | M Exercise deriv | 2023-02-28 | 2023-03-02 | 604 | — | $0 | 0 | SEC↗ |
| ACCD Accolade, Inc. | M Exercise | 2023-02-28 | 2023-03-02 | 604 | — | $0 | 5,073 | SEC↗ |
| ACCD Accolade, Inc. | M Exercise deriv | 2022-11-30 | 2022-12-02 | 603 | — | $0 | 604 | SEC↗ |
| ACCD Accolade, Inc. | M Exercise | 2022-11-30 | 2022-12-02 | 603 | — | $0 | 4,469 | SEC↗ |
| ACCD Accolade, Inc. | M Exercise deriv | 2022-08-31 | 2022-09-01 | 604 | — | $0 | 1,207 | SEC↗ |
| ACCD Accolade, Inc. | M Exercise | 2022-08-31 | 2022-09-01 | 604 | — | $0 | 3,866 | SEC↗ |
| ACCD Accolade, Inc. | A Award deriv | 2022-07-26 | 2022-07-27 | 14,060 | — | $0 | 14,060 | SEC↗ |
| ACCD Accolade, Inc. | M Exercise deriv | 2022-07-21 | 2022-07-25 | 2,659 | — | $0 | 0 | SEC↗ |
| ACCD Accolade, Inc. | M Exercise | 2022-07-21 | 2022-07-25 | 2,659 | $9.67 | $25.7K | 3,262 | SEC↗ |
| STRC Sarcos Technology & Roboti | A Award | 2022-06-29 | 2022-06-30 | 57,692 | — | $0 | 70,007 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 17,959 | — | $0 | 17,959 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2022-06-02 | 2022-06-06 | 5,986 | — | $0 | 11,313 | SEC↗ |
| ACCD Accolade, Inc. | M Exercise deriv | 2022-05-31 | 2022-06-02 | 603 | — | $0 | 1,811 | SEC↗ |
| ACCD Accolade, Inc. | M Exercise | 2022-05-31 | 2022-06-02 | 603 | — | $0 | 603 | SEC↗ |
| FFIV F5, INC. | A Award deriv | 2022-03-10 | 2022-03-11 | 1,272 | — | $0 | 1,272 | SEC↗ |
| FFIV F5, INC. | M Exercise deriv | 2022-03-09 | 2022-03-11 | 1,282 | — | $0 | 0 | SEC↗ |
| FFIV F5, INC. | M Exercise | 2022-03-09 | 2022-03-11 | 1,282 | — | $0 | 11,182 | SEC↗ |
| ACCD Accolade, Inc. | A Award deriv | 2022-03-01 | 2022-03-02 | 2,414 | — | $0 | 2,414 | SEC↗ |
| STRC Sarcos Technology & Roboti | A Award | 2021-12-09 | 2021-12-29 | 12,315 | — | $0 | 12,315 | SEC↗ |
| ACCD Accolade, Inc. | A Award deriv | 2021-07-22 | 2021-07-26 | 2,659 | — | $0 | 2,659 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2021-06-02 | 2021-06-04 | 6,222 | — | $0 | 6,222 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2021-06-02 | 2021-06-04 | 2,074 | — | $0 | 5,327 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2021-06-01 | 2021-06-03 | 3,253 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2021-06-01 | 2021-06-03 | 3,253 | — | $0 | 3,253 | SEC↗ |
| FFIV F5 NETWORKS, INC. | G Gift | 2021-05-11 | 2021-05-13 | 1,000 | — | $0 | 9,900 | SEC↗ |
| FFIV F5 NETWORKS, INC. | A Award deriv | 2021-03-11 | 2021-03-12 | 1,282 | — | $0 | 1,282 | SEC↗ |
| FFIV F5 NETWORKS, INC. | M Exercise deriv | 2021-03-10 | 2021-03-12 | 2,543 | — | $0 | 0 | SEC↗ |
| FFIV F5 NETWORKS, INC. | M Exercise | 2021-03-10 | 2021-03-12 | 2,543 | — | $0 | 10,900 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2020-06-03 | 2020-06-05 | 15,183 | — | $0 | 15,183 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2020-06-03 | 2020-06-05 | 3,253 | — | $0 | 3,253 | SEC↗ |
| FFIV F5 NETWORKS, INC. | A Award deriv | 2020-03-12 | 2020-03-13 | 2,543 | — | $0 | 2,543 | SEC↗ |
| FFIV F5 NETWORKS, INC. | M Exercise deriv | 2020-03-11 | 2020-03-13 | 1,633 | — | $0 | 0 | SEC↗ |
| FFIV F5 NETWORKS, INC. | M Exercise | 2020-03-11 | 2020-03-13 | 1,633 | — | $0 | 8,357 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2019-05-30 | 2019-05-31 | 27,245 | — | $0 | 27,245 | SEC↗ |
| FFIV F5 NETWORKS INC | A Award deriv | 2019-03-14 | 2019-03-15 | 1,633 | — | $0 | 1,633 | SEC↗ |
| FFIV F5 NETWORKS INC | M Exercise deriv | 2019-03-13 | 2019-03-15 | 1,688 | — | $0 | 0 | SEC↗ |
| FFIV F5 NETWORKS INC | M Exercise | 2019-03-13 | 2019-03-15 | 1,688 | — | $0 | 6,724 | SEC↗ |
| APTI Apptio Inc | D To issuer deriv | 2019-01-10 | 2019-01-11 | 30,000 | — | $0 | 0 | SEC↗ |
| APTI Apptio Inc | D To issuer deriv | 2019-01-10 | 2019-01-11 | 48,127 | — | $0 | 0 | SEC↗ |
| APTI Apptio Inc | D To issuer | 2019-01-10 | 2019-01-11 | 13,337 | — | $0 | 0 | SEC↗ |
| APTI Apptio Inc | M Exercise deriv | 2018-12-10 | 2018-12-12 | 8,000 | — | $0 | 48,127 | SEC↗ |
| APTI Apptio Inc | M Exercise | 2018-12-10 | 2018-12-12 | 8,000 | $9.01 | $72.1K | 21,337 | SEC↗ |
| APTI Apptio Inc | S Sale | 2018-12-10 | 2018-12-12 | 8,000 | $37.82 | $302.6K | 13,337 | SEC↗ |
| APTI Apptio Inc | M Exercise deriv | 2018-11-12 | 2018-11-14 | 8,000 | — | $0 | 56,127 | SEC↗ |
| APTI Apptio Inc | S Sale | 2018-11-12 | 2018-11-14 | 8,000 | $37.74 | $301.9K | 13,337 | SEC↗ |
| APTI Apptio Inc | M Exercise | 2018-11-12 | 2018-11-14 | 8,000 | $9.01 | $72.1K | 21,337 | SEC↗ |
| APTI Apptio Inc | M Exercise deriv | 2018-10-15 | 2018-10-17 | 8,000 | — | $0 | 64,127 | SEC↗ |
| APTI Apptio Inc | M Exercise | 2018-10-15 | 2018-10-17 | 8,000 | $9.01 | $72.1K | 21,337 | SEC↗ |
| APTI Apptio Inc | S Sale | 2018-10-15 | 2018-10-17 | 8,000 | $29.90 | $239.2K | 13,337 | SEC↗ |
| FFIV F5 NETWORKS INC | G Gift | 2018-09-14 | 2018-09-18 | 1,576 | — | $0 | 5,036 | SEC↗ |
| APTI Apptio Inc | M Exercise deriv | 2018-09-10 | 2018-09-12 | 8,000 | — | $0 | 72,127 | SEC↗ |
| APTI Apptio Inc | S Sale | 2018-09-10 | 2018-09-12 | 8,000 | $38.76 | $310.1K | 13,334 | SEC↗ |
| APTI Apptio Inc | M Exercise | 2018-09-10 | 2018-09-12 | 8,000 | $9.01 | $72.1K | 21,334 | SEC↗ |
| APTI Apptio Inc | M Exercise deriv | 2018-08-13 | 2018-08-15 | 8,000 | — | $0 | 80,127 | SEC↗ |
| APTI Apptio Inc | S Sale | 2018-08-13 | 2018-08-15 | 8,000 | $35.07 | $280.6K | 13,334 | SEC↗ |
| APTI Apptio Inc | M Exercise | 2018-08-13 | 2018-08-15 | 8,000 | $9.01 | $72.1K | 21,334 | SEC↗ |
| APTI Apptio Inc | A Award | 2018-05-30 | 2018-06-01 | 4,649 | — | $0 | 13,334 | SEC↗ |
| APTI Apptio Inc | J Other deriv | 2018-05-10 | 2018-05-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| APTI Apptio Inc | J Other deriv | 2018-05-10 | 2018-05-14 | 30,000 | — | $0 | 0 | SEC↗ |
| APTI Apptio Inc | J Other deriv | 2018-05-10 | 2018-05-14 | 88,127 | — | $0 | 0 | SEC↗ |
| APTI Apptio Inc | J Other deriv | 2018-05-10 | 2018-05-14 | 88,127 | — | $0 | 88,127 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2018-03-16 | 2018-03-20 | 37,954 | — | $0 | 37,954 | SEC↗ |
| FFIV F5 NETWORKS INC | A Award deriv | 2018-03-15 | 2018-03-16 | 1,688 | — | $0 | 1,688 | SEC↗ |
| FFIV F5 NETWORKS INC | M Exercise deriv | 2018-03-14 | 2018-03-16 | 1,740 | — | $0 | 0 | SEC↗ |
| FFIV F5 NETWORKS INC | M Exercise | 2018-03-14 | 2018-03-16 | 1,740 | — | $0 | 6,612 | SEC↗ |
| APTI Apptio Inc | A Award | 2017-07-27 | 2017-07-31 | 8,685 | — | $0 | 8,685 | SEC↗ |
| FFIV F5 NETWORKS INC | A Award deriv | 2017-03-09 | 2017-03-10 | 1,740 | — | $0 | 1,740 | SEC↗ |
| FFIV F5 NETWORKS INC | M Exercise deriv | 2017-03-08 | 2017-03-10 | 2,540 | — | $0 | 0 | SEC↗ |
| FFIV F5 NETWORKS INC | M Exercise | 2017-03-08 | 2017-03-10 | 2,540 | — | $0 | 4,872 | SEC↗ |
| FFIV F5 NETWORKS INC | A Award deriv | 2016-03-10 | 2016-09-02 | 2,540 | — | $0 | 2,540 | SEC↗ |
| FFIV F5 NETWORKS INC | A Award deriv | 2016-03-10 | 2016-03-11 | 2,540 | — | $0 | 2,540 | SEC↗ |
| FFIV F5 NETWORKS INC | M Exercise deriv | 2016-03-09 | 2016-09-02 | 2,212 | — | $0 | 0 | SEC↗ |
| FFIV F5 NETWORKS INC | M Exercise | 2016-03-09 | 2016-09-02 | 2,212 | — | $0 | 2,332 | SEC↗ |
| FFIV F5 NETWORKS INC | M Exercise deriv | 2016-03-09 | 2016-03-11 | 2,212 | — | $0 | 0 | SEC↗ |
| FFIV F5 NETWORKS INC | M Exercise | 2016-03-09 | 2016-03-11 | 2,212 | — | $0 | 2,212 | SEC↗ |
| FFIV F5 NETWORKS INC | A Award deriv | 2015-03-12 | 2015-03-13 | 2,212 | — | $0 | 2,212 | SEC↗ |
| MSFT MICROSOFT CORP | A Award | 2012-09-10 | 2012-09-12 | 123,297 | — | $0 | 471,016 | SEC↗ |
| MSFT MICROSOFT CORP | A Award | 2012-09-07 | 2012-09-11 | 123,297 | — | $0 | 358,955 | SEC↗ |
| MSFT MICROSOFT CORP | F Tax w/h | 2012-09-07 | 2012-09-11 | 11,236 | $31.35 | $352.2K | 347,719 | SEC↗ |
| MSFT MICROSOFT CORP | F Tax w/h | 2012-08-31 | 2012-09-05 | 19,857 | $30.32 | $602.1K | 235,658 | SEC↗ |
| MSFT MICROSOFT CORP | F Tax w/h | 2012-08-29 | 2012-08-31 | 960 | $30.63 | $29.4K | 255,515 | SEC↗ |